Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The physiology of porcine pancreatic islets is poorly understood.
Orexin
A is one of important agents regulating the physiology of porcine pancreatic islets. This study aimed to determine the potential effect of orexin A on the functioning of porcine pancreatic islets.
Orexin
receptor localization was done by PCR (polymerase chain reaction) and Western Blot, both in pancreatic isolated islets and whole pancreas. Secretion of insulin and
glucagon
from islets after orexin-A treatment was assayed. The viability of pig pancreatic islet cells and level of cleaved/total caspase 3 protein were measured by MTT test (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and Western blotting, respectively.
Orexin
receptors were detected in pancreatic isolated islets, and orexin-A stimulated insulin secretion and decreased
glucagon
secretion from isolated porcine islets. Moreover, we detected a protective effect of orexin A on pancreatic islet cells, which manifested as higher cell viability and lower caspase 3 activation. These findings generate a better understanding of pancreatic cells functions and perhaps provide a novel tool to prevent or alleviate negative consequences of disorders in pancreatic islets.
...
PMID:Orexin A modulates endocrine function and viability of porcine pancreatic islets. 2955 Jul 93
The hypocretin/orexin (
Hcrt
/orexin) unit affects the functions of the nervous, cardiovascular, gastrointestinal, and reproductive systems.
Hcrt
/orexin ligands and receptors have been localized to different parts of the central and peripheral nervous systems, cerebrospinal fluid and blood, exocrine (pancreas, salivary, lacrimal) as well as endocrine (pancreatic islets, pituitary, adrenal) glands. Several factors including stress,
glucagon
-like peptide-1 agonists, glutamate, nicotine, glucose, and hypoglycaemia stimulate the expression of
Hcrt
/orexin system, but it is inhibited by ageing, bone morphogenetic protein, hypoxia/hypercapnia, melanocortin receptor accessory protein 2, and
glucagon
. Literature reports show that
Hcrt
/orexin can significantly increase insulin secretion from normal and diabetic rat pancreata.
Hcrt
/orexin decreases blood glucose concentration and reduces insulin resistance partly via increased tissue expression of glucose transporter type 4. It reduces obesity by increasing browning of fat cells and energy expenditure. Taken together,
Hcrt
/orexin modulates obesity and the metabolism of glucose and insulin. The
Hcrt
/orexin system may thus be a target in the development of new therapies for the treatment of diabetes mellitus.
...
PMID:Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin. 3165 12
<< Previous
1
2